Organic Letters
Letter
M. M. Chem. Rev. 2011, 111, 2626. (g) Yus, M.; Gonzal
C.; Foubelo, F. Chem. Rev. 2011, 111, 7774.
́ ́
ez-Gomez, J.
Additional hydrogenolysis selectively afforded the quinolizine
16
10.15 Finally, displacement of the mesylate with NaN3
followed by LAH-mediated reduction of the azide17 gave the
expected (+)-epilupinamine 11 (Scheme 1).
(2) (a) Tan, K. L.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2007, 46,
1315. (b) Huber, J. D.; Perl, N. R.; Leighton, J. L. Angew. Chem., Int.
Ed. 2008, 47, 3037. (c) Kobayashi, S.; Ogawa, C.; Konishi, H.; Sugiura,
M. J. Am. Chem. Soc. 2003, 125, 6610. (d) Kobayashi, S.; Sugiura, M.;
Ogawa, C. Adv. Synth. Catal. 2004, 346, 1023. (e) Kolodney, G.;
Sklute, G.; Perrone, S.; Knochel, P.; Marek, I. Angew. Chem., Int. Ed.
2007, 46, 9291. (f) Schulte, M. L.; Lindsley, C. W. Org. Lett. 2011, 13,
5684. (g) Yuan, B.-H.; Zhang, Z.-C.; Liu, W.-J.; Sun, X.-W. Tetrahedron
Lett. 2016, 57, 2147. (h) Bosque, I.; Bagdatli, E.; Foubelo, F.;
Gonzalez-Gomez, J. C. J. Org. Chem. 2014, 79, 1796. (i) Delaye, P.-O.;
Vasse, J.-L.; Szymoniak, J. Org. Biomol. Chem. 2010, 8, 3635.
(j) Lysenko, I. L.; Lee, H. G.; Cha, J. K. Org. Lett. 2009, 11, 3132.
(k) Takahashi, M.; McLaughlin, M.; Micalizio, G. C. Angew. Chem., Int.
Ed. 2009, 48, 3648.
Scheme 1. Synthesis of (+)-Epilupinamine
(3) Soares do Rego Barros, O.; Sirvent, J. A.; Foubelo, F.; Yus, M.
Chem. Commun. 2014, 50, 6898.
(4) Huber, J. D.; Leighton, J. L. J. Am. Chem. Soc. 2007, 129, 14552.
(5) Reddy, L. R.; Hu, B.; Prashad, M.; Prasad, K. Org. Lett. 2008, 10,
3109.
(6) (a) Cai, S.-L.; Song, R.; Dong, H.-Q.; Lin, G.-Q.; Sun, X.-W. Org.
Lett. 2016, 18, 1996. (b) Lee, C.-L. K.; Ling, H. Y.; Loh, T.-P. J. Org.
Chem. 2004, 69, 7787. (c) Chen, D.; Xu, M.-H. Chem. Commun. 2013,
49, 1327. (d) Liu, M.; Shen, A.; Sun, X.-W.; Deng, F.; Xu, M.-H.; Lin,
G.-Q. Chem. Commun. 2010, 46, 8460.
(7) (a) Schulte, M. L.; Lindsley, C. W. Org. Lett. 2011, 13, 5684.
(b) Arena, G.; Zill, N.; Salvadori, J.; Girard, N.; Mann, A.; Taddei, M.
Org. Lett. 2011, 13, 2294. (c) Yanada, R.; Kaieda, A.; Takemoto, Y. J.
In summary, a syn-selective asymmetric access to homoallylic
amines involving racemic cyclohexen- and cyclopenten-1-
ylalane based on a camphor-mediated kinetic resolution is
presented. This approach makes the cyclohexen-1-ylalane in
situ available in a highly enantioenriched form, allowing the
coupling with prochiral imine. In contrast, cyclopenten-1-
ylalane is less efficiently resolved. However, the use of
cooperatively configurated tert-butylsulfinamide-derived imine
afforded the homoallylic amine with high diastereoselectivity by
means of a second matching kinetic resolution. These two
complementary approaches allow access to synthetically useful
building blocks as illustrated by the synthesis of (+)-epilupin-
amine.
́ ́
Org. Chem. 2001, 66, 7516. (d) Gonzalez-Gomez, J. C.; Medjahdi, M.;
Foubelo, F.; Yus, M. J. Org. Chem. 2010, 75, 6308.
(8) (a) Han, J. W.; Hayashi, T. Tetrahedron: Asymmetry 2002, 13,
325. (b) Li, D.; Tanaka, T.; Ohmiya, H.; Sawamura, M. Org. Lett.
2010, 12, 3344. (c) Hayashi, T.; Han, J. W.; Takeda, A.; Tang, J.;
Nohmi, K.; Mukaide, K.; Tsuji, H.; Uozumi, Y. Adv. Synth. Catal. 2001,
343, 279.
(9) (a) Gonzalez, E.; Munoz-Hernandez, L.; Alicea, E.; Singaram, B.;
̃
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge on the
■
Kabalka, G. W.; Soderquist, J. A. Org. Lett. 2015, 17, 4368. (b) Brown,
H. C.; Bhat, K. S.; Jadhav, P. K. J. Chem. Soc., Perkin Trans. 1 1991,
2633. (c) Ito, H.; Kunii, S.; Sawamura, M. Nat. Chem. 2010, 2, 972.
(d) Sasaki, Y.; Zhong, C.; Sawamura, M.; Ito, H. J. Am. Chem. Soc.
2010, 132, 1226.
(10) Coffinet, M.; Massicot, F.; Joseph, J.; Behr, J.-B.; Jaroschik, F.;
Vasse, J.-L. Chem. Commun. 2017, 53, 111.
(11) Coffinet, M.; Lamy, S.; Jaroschik, F.; Vasse, J.-L. Org. Biomol.
Chem. 2016, 14, 69.
S
1
Experimental procedures, characterization, and H and
13C NMR spectra of all new compounds (PDF)
(12) (a) Michael, J. P.; Jungmann, C. M. Tetrahedron 1992, 48,
10211. (b) Rusconi, C.; Vaiana, N.; Casagrande, M.; Basilico, N.;
Parapini, S.; Taramelli, D.; Romeo, S.; Sparatore, A. Bioorg. Med. Chem.
2012, 20, 5980.
(13) (a) Chen, Q.; Li, J.; Yuan, C. Synthesis 2008, 2008, 2986.
(b) Leemans, E.; Mangelinckx, S.; De Kimpe, N. Chem. Commun.
2010, 46, 3122. (c) Louvel, J.; Chemla, F.; Demont, E.; Ferreira, F.;
Perez-Luna, A.; Voituriez, A. Adv. Synth. Catal. 2011, 353, 2137.
(14) (a) Zhou, J.; Hartwig, J. F. J. Am. Chem. Soc. 2008, 130, 12220.
(b) Celestini, P.; Danieli, B.; Lesma, G.; Sacchetti, A.; Silvani, A.;
Passarella, D.; Virdis, A. Org. Lett. 2002, 4, 1367.
AUTHOR INFORMATION
■
Corresponding Author
ORCID
Notes
The authors declare no competing financial interest.
(15) For similar selective cyclization, see: (a) Kondekar, N. B.;
Kumar, P. Synthesis 2010, 2010, 3105. (b) Huy, P. H.; Koskinen, A. M.
ACKNOWLEDGMENTS
We thank MNRT and CNRS for financial support and Anthony
Robert (ICMR-UMR7312) for technical assistance.
■
́ ́
P. Org. Lett. 2013, 15, 5178. (c) Ledoux, S.; Marchalant, E.; Celerier,
J.-P.; Lhommet, G. Tetrahedron Lett. 2001, 42, 5397. (d) Matin, M.
M.; Sharma, T.; Sabharwal, S. G.; Dhavale, D. D. Org. Biomol. Chem.
2005, 3, 1702.
REFERENCES
■
(16) Danieli, B.; Lesma, G.; Passarella, D.; Silvani, A.; Viviani, N.
Tetrahedron 1999, 55, 11871.
(17) Watkin, S. V.; Camp, N. P.; Brown, R. C. D. Org. Lett. 2013, 15,
4596.
(1) (a) Yamamoto, Y.; Asao, N. Chem. Rev. 1993, 93, 2207.
(b) Merino, P.; Tejero, T.; Delso, J. I.; Mannucci, V. Curr. Org. Synth.
2005, 2, 479. (c) Ding, H.; Friestad, G. K. Synthesis 2005, 2005, 2815.
(d) Kargbo, R. B.; Cook, G. R. Curr. Org. Chem. 2007, 11, 1287.
(e) Kanai, M.; Wada, R.; Shibuguchi, T.; Shibasaki, M. Pure Appl.
Chem. 2008, 80, 1055. (f) Kobayashi, S.; Mori, Y.; Fossey, J. S.; Salter,
6731
Org. Lett. 2017, 19, 6728−6731